Cardiac function in mice lacking the glucagon-like peptide-1 receptor.
暂无分享,去创建一个
D. Drucker | I. Mungrue | L. Baggio | M. Husain | R. Gros | M. G. Kabir | Qingling Huang | T. Parker | Imran N. Mungrue | X. You | A. Sadi | M. Golam Kabir | Toronto General | Robert Gros | Xiao-Mang You | M. G. Kabir | Al Muktafi Sadi | Thomas G. Parker
[1] Wallace C. Wu,et al. Glucagon effects on the human small intestine , 1979, Digestive Diseases and Sciences.
[2] D. Drucker,et al. International Union of Pharmacology. XXXV. The Glucagon Receptor Family , 2003, Pharmacological Reviews.
[3] D. Drucker. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. , 2003, Molecular endocrinology.
[4] C. Saper,et al. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. , 2002, The Journal of clinical investigation.
[5] B. Janssen,et al. Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[6] D. Stewart,et al. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. , 2002, The Journal of clinical investigation.
[7] J. Holst,et al. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study , 2002, The Lancet.
[8] B. Janssen,et al. Chronic measurement of cardiac output in conscious mice. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[9] D. Drucker. Biological actions and therapeutic potential of the glucagon-like peptides. , 2002, Gastroenterology.
[10] J. Stock,et al. Glycemic control in mice with targeted disruption of the glucagon receptor gene. , 2002, Biochemical and biophysical research communications.
[11] T. Welte,et al. Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat , 2001, Regulatory Peptides.
[12] M. Bjerknes,et al. Modulation of specific intestinal epithelial progenitors by enteric neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Astrup,et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.
[14] S. Sollott,et al. Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes , 2001, Circulation research.
[15] D. Drucker. Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes. , 2001, Current pharmaceutical design.
[16] D. Drucker,et al. Minireview: the glucagon-like peptides. , 2001, Endocrinology.
[17] G L Freeman,et al. Validation of a mouse conductance system to determine LV volume: comparison to echocardiography and crystals. , 2000, American journal of physiology. Heart and circulatory physiology.
[18] B. Yusta,et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. , 2000, Gastroenterology.
[19] C. Saper,et al. Chemical characterization of leptin‐activated neurons in the rat brain , 2000, The Journal of comparative neurology.
[20] S. Woods,et al. The Role of CNS Glucagon-Like Peptide-1 (7-36) Amide Receptors in Mediating the Visceral Illness Effects of Lithium Chloride , 2000, The Journal of Neuroscience.
[21] D. Drucker,et al. The Glucagon Receptor Family , 2000 .
[22] J. Habener,et al. The glucagon-like peptides. , 1999, Endocrine reviews.
[23] E. Blázquez,et al. Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. , 1999, American journal of physiology. Endocrinology and metabolism.
[24] G. V. Dijk,et al. Glucagon-like peptide-1 (7–36) amide: a central regulator of satiety and interoceptive stress , 1999, Neuropeptides.
[25] J. Holst. Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential , 1999, Trends in Endocrinology & Metabolism.
[26] L. Rinaman. Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. , 1999, The American journal of physiology.
[27] J. Holst,et al. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. , 1999, Diabetes care.
[28] D. Drucker. Glucagon-like Peptide 2 , 1999, Trends in Endocrinology & Metabolism.
[29] C. M. White. A Review of Potential Cardiovascular Uses of Intravenous Glucagon Administration , 1999, Journal of clinical pharmacology.
[30] D. Drucker,et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[31] P. Shughrue,et al. Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system , 1999, The Journal of comparative neurology.
[32] J. Holst,et al. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. , 1998, The Journal of clinical investigation.
[33] J. Howell,et al. A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia. , 1998, Chest.
[34] D. Drucker,et al. Effects of Aging and a High Fat Diet on Body Weight and Glucose Tolerance in Glucagon-Like Peptide-1 Receptor-/- Mice. , 1998, Endocrinology.
[35] J. Dunphy,et al. Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression 1 This work was supported by a grant from the Crohn's and Colitis Foundation of America. 1 , 1998, Molecular and Cellular Endocrinology.
[36] D. Drucker,et al. Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice. , 1998, Endocrinology.
[37] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[38] S. Bloom,et al. Cardiovascular and pancreatic endocrine responses to glucagon‐like peptide‐1(7–36) amide in the conscious calf , 1997, Experimental physiology.
[39] B. Göke,et al. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. , 1997, Proceedings of the Association of American Physicians.
[40] E. Blázquez,et al. Interactions of exendin-(9–39) with the effects of glucagon-like peptide-1-(7–36) amide and of exendin-4 on arterial blood pressure and heart rate in rats , 1996, Regulatory Peptides.
[41] A. Joyner,et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.
[42] D. Drucker,et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Habener,et al. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. , 1996, Endocrinology.
[44] B. Thorens,et al. Expression of the Glucagon‐Like Peptide‐1 Receptor Gene in Rat Brain , 1996, Journal of neurochemistry.
[45] D. Smith,et al. A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.
[46] F. Pecker,et al. Synergistic actions of glucagon and miniglucagon on Ca2+ mobilization in cardiac cells. , 1996, Circulation research.
[47] S. Mojsov,et al. Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences , 1995, FEBS letters.
[48] P. Robberecht,et al. Relative quantitative analysis of glucagon receptor mRNA in rat tissues , 1994, Molecular and Cellular Endocrinology.
[49] D. Drucker,et al. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. , 1994, Endocrinology.
[50] E. Blázquez,et al. Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. , 1994, The American journal of physiology.
[51] C. Strader,et al. Cloning and expression of a human glucagon receptor. , 1994, Biochemical and biophysical research communications.
[52] B. Göke,et al. GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. , 1993, The American journal of physiology.
[53] H. Eiskjær,et al. Effect of intravenous glucagon infusion on renal haemodynamics and renal tubular handling of sodium in healthy humans , 1993 .
[54] H. Orskov,et al. Effect of intravenous glucagon infusion on renal haemodynamics and renal tubular handling of sodium in healthy humans. , 1993, Scandinavian journal of clinical and laboratory investigation.
[55] B. Thorens. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[56] L. Bankir,et al. Effects of glucagon on glomerular filtration rate and urea and water excretion. , 1992, The American journal of physiology.
[57] R. Fischmeister,et al. Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase , 1990, Nature.
[58] H. Drexler,et al. Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody. , 1990, Circulation research.
[59] N. Reichek,et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[60] Y. Oomura,et al. Effect of intracerebroventricularly infused glucagon on feeding behavior , 1984, Physiology & Behavior.
[61] A. Farah. Glucagon and the circulation. , 1983, Pharmacological reviews.
[62] N. Fortuin,et al. The evaluation of left ventricular function by echocardiography. , 1977, The American journal of medicine.
[63] W. Parmley,et al. Cardiovascular effects of glucagon in man. , 1968, The New England journal of medicine.
[64] H. Necheles,et al. Effect of glucagon on gastrointestinal motility. , 1966, The American journal of gastroenterology.
[65] S. Nef,et al. microRNAs in the testis: building up male fertility. , 2010, Journal of andrology.